{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T05:42:42Z","timestamp":1777268562894,"version":"3.51.4"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100016308","name":"Wuxi Health and Family Planning Commission","doi-asserted-by":"publisher","award":["Wuxi Taihu Lake Talent Plan"],"award-info":[{"award-number":["Wuxi Taihu Lake Talent Plan"]}],"id":[{"id":"10.13039\/501100016308","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071381"],"award-info":[{"award-number":["82071381"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s11064-026-04726-6","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T10:50:38Z","timestamp":1773658238000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["GPR40 Attenuates Glioma TMZ-Resistance Through Ferroptosis Inhibition"],"prefix":"10.1007","volume":"51","author":[{"given":"Jieqiong","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shenqian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenqian","family":"Mu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zengli","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xudong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiting","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"issue":"1","key":"4726_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41572-024-00516-y","volume":"10","author":"M Weller","year":"2024","unstructured":"Weller M, Wen PY, Chang SM, Dirven L, Lim M, Monje M, Reifenberger G (2024) Glioma. Nat Rev Dis Primers 10(1):33","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"4726_CR2","first-page":"299","volume":"70","author":"AC Tan","year":"2020","unstructured":"Tan AC, Ashley DM, Lopez GY, Malinzak M, Friedman HS, Khasraw M (2020) Management of glioblastoma: State of the art and future directions. CA Cancer J Clin 70(4):299\u2013312","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"4726_CR3","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJMoa1308573","volume":"370","author":"MR Gilbert","year":"2014","unstructured":"Gilbert MR, Dignam JJ, Armstrong TS, Wefel JS, Blumenthal DT, Vogelbaum MA, Colman H, Chakravarti A, Pugh S, Won M et al (2014) A randomized trial of bevacizumab for newly diagnosed glioblastoma. N Engl J Med 370(8):699\u2013708","journal-title":"N Engl J Med"},{"issue":"2","key":"4726_CR4","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s11060-020-03451-6","volume":"147","author":"L Marenco-Hillembrand","year":"2020","unstructured":"Marenco-Hillembrand L, Wijesekera O, Suarez-Meade P, Mampre D, Jackson C, Peterson J, Trifiletti D, Hammack J, Ortiz K, Lesser E et al (2020) Trends in glioblastoma: outcomes over time and type of intervention: a systematic evidence based analysis. J Neurooncol 147(2):297\u2013307","journal-title":"J Neurooncol"},{"issue":"1","key":"4726_CR5","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s11060-017-2564-z","volume":"135","author":"ME van Linde","year":"2017","unstructured":"van Linde ME, Brahm CG, de Witt Hamer PC, Reijneveld JC, Bruynzeel AME, Vandertop WP, van de Ven PM, Wagemakers M, van der Weide HL, Enting RH et al (2017) Treatment outcome of patients with recurrent glioblastoma multiforme: a retrospective multicenter analysis. J Neurooncol 135(1):183\u2013192","journal-title":"J Neurooncol"},{"issue":"11","key":"4726_CR6","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1093\/neuonc\/noaa059","volume":"22","author":"R Mathur","year":"2020","unstructured":"Mathur R, Zhang Y, Grimmer MR, Hong C, Zhang M, Bollam S, Petrecca K, Clarke J, Berger MS, Phillips JJ et al (2020) MGMT promoter methylation level in newly diagnosed low-grade glioma is a predictor of hypermutation at recurrence. Neuro Oncol 22(11):1580\u20131590","journal-title":"Neuro Oncol"},{"key":"4726_CR7","doi-asserted-by":"publisher","first-page":"100743","DOI":"10.1016\/j.drup.2021.100743","volume":"54","author":"JQ Wang","year":"2021","unstructured":"Wang JQ, Yang Y, Cai CY, Teng QX, Cui Q, Lin J, Assaraf YG, Chen ZS (2021) Multidrug resistance proteins (MRPs): Structure, function and the overcoming of cancer multidrug resistance. Drug Resist Updat 54:100743","journal-title":"Drug Resist Updat"},{"key":"4726_CR8","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.semcancer.2020.12.015","volume":"83","author":"MS Uddin","year":"2022","unstructured":"Uddin MS, Mamun AA, Alghamdi BS, Tewari D, Jeandet P, Sarwar MS, Ashraf GM (2022) Epigenetics of glioblastoma multiforme: From molecular mechanisms to therapeutic approaches. Semin Cancer Biol 83:100\u2013120","journal-title":"Semin Cancer Biol"},{"issue":"Pt 2","key":"4726_CR9","doi-asserted-by":"publisher","first-page":"116588","DOI":"10.1016\/j.bcp.2024.116588","volume":"230","author":"Q Tang","year":"2024","unstructured":"Tang Q, Ren T, Bai P, Wang X, Zhao L, Zhong R, Sun G (2024) Novel strategies to overcome chemoresistance in human glioblastoma. Biochem Pharmacol 230(Pt 2):116588","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"4726_CR10","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.trecan.2020.02.010","volume":"6","author":"M Butler","year":"2020","unstructured":"Butler M, Pongor L, Su YT, Xi L, Raffeld M, Quezado M, Trepel J, Aldape K, Pommier Y, Wu J (2020) MGMT Status as a Clinical Biomarker in Glioblastoma. Trends Cancer 6(5):380\u2013391","journal-title":"Trends Cancer"},{"issue":"3","key":"4726_CR11","doi-asserted-by":"publisher","first-page":"119673","DOI":"10.1016\/j.bbamcr.2024.119673","volume":"1871","author":"R Shaw","year":"2024","unstructured":"Shaw R, Basu M, Karmakar S, Ghosh MK (2024) MGMT in TMZ-based glioma therapy: Multifaceted insights and clinical trial perspectives. Biochim Biophys Acta Mol Cell Res 1871(3):119673","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"4726_CR12","doi-asserted-by":"crossref","unstructured":"Chang C, Chavarro VS, Gerstl JVE, Blitz SE, Spanehl L, Dubinski D, Valdes PA, Tran LN, Gupta S, Esposito L et al (2024) Recurrent Glioblastoma-Molecular Underpinnings and Evolving Treatment Paradigms. Int J Mol Sci 25(12)","DOI":"10.3390\/ijms25126733"},{"key":"4726_CR13","doi-asserted-by":"publisher","first-page":"1238233","DOI":"10.3389\/fimmu.2023.1238233","volume":"14","author":"L Zhang","year":"2023","unstructured":"Zhang L, Jiang Y, Zhang G, Wei S (2023) The diversity and dynamics of tumor-associated macrophages in recurrent glioblastoma. Front Immunol 14:1238233","journal-title":"Front Immunol"},{"key":"4726_CR14","doi-asserted-by":"publisher","first-page":"831636","DOI":"10.3389\/fimmu.2022.831636","volume":"13","author":"K Kanwore","year":"2022","unstructured":"Kanwore K, Kanwore K, Adzika GK, Abiola AA, Guo X, Kambey PA, Xia Y, Gao D (2022) Cancer Metabolism: The Role of Immune Cells Epigenetic Alteration in Tumorigenesis, Progression, and Metastasis of Glioma. Front Immunol 13:831636","journal-title":"Front Immunol"},{"key":"4726_CR15","doi-asserted-by":"crossref","unstructured":"Nguyen TTT, Shang E, Westhoff MA, Karpel-Massler G, Siegelin MD (2022) Therapeutic Drug-Induced Metabolic Reprogramming in Glioblastoma. Cells 11(19)","DOI":"10.3390\/cells11192956"},{"issue":"5","key":"4726_CR16","doi-asserted-by":"publisher","first-page":"189168","DOI":"10.1016\/j.bbcan.2024.189168","volume":"1879","author":"M Kundu","year":"2024","unstructured":"Kundu M, Das S, Dey A, Mandal M (2024) Dual perspective on autophagy in glioma: Detangling the dichotomous mechanisms of signaling pathways for therapeutic insights. Biochim Biophys Acta Rev Cancer 1879(5):189168","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"2","key":"4726_CR17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2021","unstructured":"Tang D, Chen X, Kang R, Kroemer G (2021) Ferroptosis: molecular mechanisms and health implications. Cell Res 31(2):107\u2013125","journal-title":"Cell Res"},{"issue":"5","key":"4726_CR18","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/s41556-019-0305-6","volume":"21","author":"B Chu","year":"2019","unstructured":"Chu B, Kon N, Chen D, Li T, Liu T, Jiang L, Song S, Tavana O, Gu W (2019) ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway. Nat Cell Biol 21(5):579\u2013591","journal-title":"Nat Cell Biol"},{"issue":"7769","key":"4726_CR19","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41586-019-1426-6","volume":"572","author":"J Wu","year":"2019","unstructured":"Wu J, Minikes AM, Gao M, Bian H, Li Y, Stockwell BR, Chen ZN, Jiang X (2019) Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling. Nature 572(7769):402\u2013406","journal-title":"Nature"},{"issue":"1","key":"4726_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12964-023-01108-1","volume":"21","author":"S Wan","year":"2023","unstructured":"Wan S, Zhang G, Liu R, Abbas MN, Cui H (2023) Pyroptosis, ferroptosis, and autophagy cross-talk in glioblastoma opens up new avenues for glioblastoma treatment. Cell Commun Signal 21(1):115","journal-title":"Cell Commun Signal"},{"issue":"2","key":"4726_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ccell.2020.06.001","volume":"38","author":"JD Hayes","year":"2020","unstructured":"Hayes JD, Dinkova-Kostova AT, Tew KD (2020) Oxidative Stress in Cancer. Cancer Cell 38(2):167\u2013197","journal-title":"Cancer Cell"},{"key":"4726_CR22","doi-asserted-by":"crossref","unstructured":"Miska J, Chandel NS (2023) Targeting fatty acid metabolism in glioblastoma. J Clin Invest 133(1)","DOI":"10.1172\/JCI163448"},{"issue":"5","key":"4726_CR23","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.cell.2020.04.039","volume":"181","author":"K Hadian","year":"2020","unstructured":"Hadian K, Stockwell BR (2020) SnapShot: Ferroptosis. Cell 181(5):1188\u20131188 e1181","journal-title":"Cell"},{"issue":"4","key":"4726_CR24","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M (2021) Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol 22(4):266\u2013282","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4726_CR25","doi-asserted-by":"crossref","unstructured":"Mitre AO, Florian AI, Buruiana A, Boer A, Moldovan I, Soritau O, Florian SI, Susman S (2022) Ferroptosis Involvement in Glioblastoma Treatment. Med (Kaunas) 58(2)","DOI":"10.3390\/medicina58020319"},{"issue":"289","key":"4726_CR26","doi-asserted-by":"publisher","first-page":"289ra286","DOI":"10.1126\/scitranslmed.aaa8103","volume":"7","author":"SM Robert","year":"2015","unstructured":"Robert SM, Buckingham SC, Campbell SL, Robel S, Holt KT, Ogunrinu-Babarinde T, Warren PP, White DM, Reid MA, Eschbacher JM et al (2015) SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma. Sci Transl Med 7(289):289ra286","journal-title":"Sci Transl Med"},{"issue":"3","key":"4726_CR27","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.3892\/or.2015.3712","volume":"33","author":"L Chen","year":"2015","unstructured":"Chen L, Li X, Liu L, Yu B, Xue Y, Liu Y (2015) Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine-gamma-lyase function. Oncol Rep 33(3):1465\u20131474","journal-title":"Oncol Rep"},{"issue":"1","key":"4726_CR28","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1152\/physrev.00041.2018","volume":"100","author":"I Kimura","year":"2020","unstructured":"Kimura I, Ichimura A, Ohue-Kitano R, Igarashi M (2020) Free Fatty Acid Receptors in Health and Disease. Physiol Rev 100(1):171\u2013210","journal-title":"Physiol Rev"},{"key":"4726_CR29","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.plipres.2015.01.002","volume":"58","author":"T Yamashima","year":"2015","unstructured":"Yamashima T (2015) Dual effects of the non-esterified fatty acid receptor \u2018GPR40\u2019 for human health. Prog Lipid Res 58:40\u201350","journal-title":"Prog Lipid Res"},{"issue":"4","key":"4726_CR30","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.neures.2007.05.001","volume":"58","author":"D Ma","year":"2007","unstructured":"Ma D, Tao B, Warashina S, Kotani S, Lu L, Kaplamadzhiev DB, Mori Y, Tonchev AB, Yamashima T (2007) Expression of free fatty acid receptor GPR40 in the central nervous system of adult monkeys. Neurosci Res 58(4):394\u2013401","journal-title":"Neurosci Res"},{"issue":"7","key":"4726_CR31","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/S0165-6147(00)01678-3","volume":"22","author":"MJ Marinissen","year":"2001","unstructured":"Marinissen MJ, Gutkind JS (2001) G-protein-coupled receptors and signaling networks: emerging paradigms. Trends Pharmacol Sci 22(7):368\u2013376","journal-title":"Trends Pharmacol Sci"},{"issue":"Pt B","key":"4726_CR32","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.neuropharm.2015.05.013","volume":"113","author":"MZ Khan","year":"2017","unstructured":"Khan MZ, He L (2017) The role of polyunsaturated fatty acids and GPR40 receptor in brain. Neuropharmacology 113(Pt B):639\u2013651","journal-title":"Neuropharmacology"},{"issue":"2","key":"4726_CR33","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/med.21441","volume":"38","author":"Z Li","year":"2018","unstructured":"Li Z, Xu X, Huang W, Qian H (2018) Free Fatty Acid Receptor 1 (FFAR1) as an Emerging Therapeutic Target for Type 2 Diabetes Mellitus: Recent Progress and Prevailing Challenges. Med Res Rev 38(2):381\u2013425","journal-title":"Med Res Rev"},{"issue":"5","key":"4726_CR34","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1111\/bph.13003","volume":"172","author":"K Nakamoto","year":"2015","unstructured":"Nakamoto K, Nishinaka T, Sato N, Aizawa F, Yamashita T, Mankura M, Koyama Y, Kasuya F, Tokuyama S (2015) The activation of supraspinal GPR40\/FFA1 receptor signalling regulates the descending pain control system. Br J Pharmacol 172(5):1250\u20131262","journal-title":"Br J Pharmacol"},{"issue":"1","key":"4726_CR35","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12974-017-0869-7","volume":"14","author":"NRV Dragano","year":"2017","unstructured":"Dragano NRV, Solon C, Ramalho AF, de Moura RF, Razolli DS, Christiansen E, Azevedo C, Ulven T, Velloso LA (2017) Polyunsaturated fatty acid receptors, GPR40 and GPR120, are expressed in the hypothalamus and control energy homeostasis and inflammation. J Neuroinflammation 14(1):91","journal-title":"J Neuroinflammation"},{"key":"4726_CR36","doi-asserted-by":"publisher","first-page":"699026","DOI":"10.3389\/fphar.2021.699026","volume":"12","author":"Y Sadamura","year":"2021","unstructured":"Sadamura Y, Thapa S, Mizunuma R, Kambe Y, Hirasawa A, Nakamoto K, Tokuyama S, Yoshimoto K, Arita K, Miyata A et al (2021) FFAR1\/GPR40 Contributes to the Regulation of Striatal Monoamine Releases and Facilitation of Cocaine-Induced Locomotor Activity in Mice. Front Pharmacol 12:699026","journal-title":"Front Pharmacol"},{"issue":"1","key":"4726_CR37","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12935-023-02967-x","volume":"23","author":"PF Karmokar","year":"2023","unstructured":"Karmokar PF, Moniri NH (2023) Free-fatty acid receptor-1 (FFA1\/GPR40) promotes papillary RCC proliferation and tumor growth via Src\/PI3K\/AKT\/NF-kappaB but suppresses migration by inhibition of EGFR, ERK1\/2, STAT3 and EMT. Cancer Cell Int 23(1):126","journal-title":"Cancer Cell Int"},{"issue":"9","key":"4726_CR38","doi-asserted-by":"publisher","first-page":"7367","DOI":"10.1002\/jcp.26572","volume":"233","author":"A Liotti","year":"2018","unstructured":"Liotti A, Cosimato V, Mirra P, Cali G, Conza D, Secondo A, Luongo G, Terracciano D, Formisano P, Beguinot F et al (2018) Oleic acid promotes prostate cancer malignant phenotype via the G protein-coupled receptor FFA1\/GPR40. J Cell Physiol 233(9):7367\u20137378","journal-title":"J Cell Physiol"},{"issue":"65","key":"4726_CR39","doi-asserted-by":"publisher","first-page":"109135","DOI":"10.18632\/oncotarget.22629","volume":"8","author":"S Zhu","year":"2017","unstructured":"Zhu S, Lin G, Song C, Wu Y, Feng N, Chen W, He Z, Chen YQ (2017) RA and omega-3 PUFA co-treatment activates autophagy in cancer cells. Oncotarget 8(65):109135\u2013109150","journal-title":"Oncotarget"},{"issue":"4","key":"4726_CR40","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1080\/10799893.2018.1494742","volume":"38","author":"K Fukushima","year":"2018","unstructured":"Fukushima K, Takahashi K, Kusaka M, Ishimoto K, Minami K, Otagaki S, Fukushima N, Honoki K, Tsujiuchi T (2018) Induction of GPR40 positively regulates cell motile and growth activities in breast cancer MCF-7 cells. J Recept Signal Transduct Res 38(4):311\u2013315","journal-title":"J Recept Signal Transduct Res"},{"key":"4726_CR41","doi-asserted-by":"publisher","first-page":"115328","DOI":"10.1016\/j.bcp.2022.115328","volume":"206","author":"PF Karmokar","year":"2022","unstructured":"Karmokar PF, Moniri NH (2022) Oncogenic signaling of the free-fatty acid receptors FFA1 and FFA4 in human breast carcinoma cells. Biochem Pharmacol 206:115328","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"4726_CR42","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13046-019-1040-3","volume":"38","author":"X Chu","year":"2019","unstructured":"Chu X, Zhou Q, Xu Y, Jiang J, Li Q, Zhou Q, Wu Q, Jin M, Wang H, Gu Y et al (2019) Aberrant fatty acid profile and FFAR4 signaling confer endocrine resistance in breast cancer. J Exp Clin Cancer Res 38(1):100","journal-title":"J Exp Clin Cancer Res"},{"issue":"7","key":"4726_CR43","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1001\/jama.2023.0023","volume":"329","author":"LR Schaff","year":"2023","unstructured":"Schaff LR, Mellinghoff IK (2023) Glioblastoma and Other Primary Brain Malignancies in Adults: A Review. JAMA 329(7):574\u2013587","journal-title":"JAMA"},{"issue":"1","key":"4726_CR44","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1038\/s41467-019-10025-2","volume":"10","author":"P Wu","year":"2019","unstructured":"Wu P, Cai J, Chen Q, Han B, Meng X, Li Y, Li Z, Wang R, Lin L, Duan C et al (2019) Lnc-TALC promotes O(6)-methylguanine-DNA methyltransferase expression via regulating the c-Met pathway by competitively binding with miR-20b-3p. Nat Commun 10(1):2045","journal-title":"Nat Commun"},{"issue":"101","key":"4726_CR45","doi-asserted-by":"publisher","first-page":"ra82","DOI":"10.1126\/scisignal.2000446","volume":"2","author":"D Guo","year":"2009","unstructured":"Guo D, Prins RM, Dang J, Kuga D, Iwanami A, Soto H, Lin KY, Huang TT, Akhavan D, Hock MB et al (2009) EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy. Sci Signal 2(101):ra82","journal-title":"Sci Signal"},{"issue":"11","key":"4726_CR46","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1002\/cac2.12361","volume":"42","author":"E Verdugo","year":"2022","unstructured":"Verdugo E, Puerto I, Medina MA (2022) An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatment. Cancer Commun (Lond) 42(11):1083\u20131111","journal-title":"Cancer Commun (Lond)"},{"issue":"6","key":"4726_CR47","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.ccell.2023.05.001","volume":"41","author":"JK Minami","year":"2023","unstructured":"Minami JK, Morrow D, Bayley NA, Fernandez EG, Salinas JJ, Tse C, Zhu H, Su B, Plawat R, Jones A et al (2023) CDKN2A deletion remodels lipid metabolism to prime glioblastoma for ferroptosis. Cancer Cell 41(6):1048\u20131060 e1049","journal-title":"Cancer Cell"},{"issue":"2","key":"4726_CR48","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.pneurobio.2007.11.002","volume":"84","author":"T Yamashima","year":"2008","unstructured":"Yamashima T (2008) A putative link of PUFA, GPR40 and adult-born hippocampal neurons for memory. Prog Neurobiol 84(2):105\u2013115","journal-title":"Prog Neurobiol"},{"issue":"6928","key":"4726_CR49","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/nature01478","volume":"422","author":"Y Itoh","year":"2003","unstructured":"Itoh Y, Kawamata Y, Harada M, Kobayashi M, Fujii R, Fukusumi S, Ogi K, Hosoya M, Tanaka Y, Uejima H et al (2003) Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40. Nature 422(6928):173\u2013176","journal-title":"Nature"},{"issue":"22","key":"4726_CR50","doi-asserted-by":"publisher","first-page":"e2219569120","DOI":"10.1073\/pnas.2219569120","volume":"120","author":"P Kumari","year":"2023","unstructured":"Kumari P, Inoue A, Chapman K, Lian P, Rosenbaum DM (2023) Molecular mechanism of fatty acid activation of FFAR1. Proc Natl Acad Sci U S A 120(22):e2219569120","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"4726_CR51","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.trecan.2020.10.004","volume":"7","author":"M Bacci","year":"2021","unstructured":"Bacci M, Lorito N, Smiriglia A, Morandi A (2021) Fat and Furious: Lipid Metabolism in Antitumoral Therapy Response and Resistance. Trends Cancer 7(3):198\u2013213","journal-title":"Trends Cancer"},{"issue":"3","key":"4726_CR52","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/s41401-022-00984-6","volume":"44","author":"M Choo","year":"2023","unstructured":"Choo M, Mai VH, Kim HS, Kim DH, Ku JL, Lee SK, Park CK, An YJ, Park S (2023) Involvement of cell shape and lipid metabolism in glioblastoma resistance to temozolomide. Acta Pharmacol Sin 44(3):670\u2013679","journal-title":"Acta Pharmacol Sin"},{"issue":"6","key":"4726_CR53","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41419-022-04997-1","volume":"13","author":"Z Miao","year":"2022","unstructured":"Miao Z, Tian W, Ye Y, Gu W, Bao Z, Xu L, Sun G, Li C, Tu Y, Chao H et al (2022) Hsp90 induces Acsl4-dependent glioma ferroptosis via dephosphorylating Ser637 at Drp1. Cell Death Dis 13(6):548","journal-title":"Cell Death Dis"},{"issue":"1","key":"4726_CR54","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s13046-022-02518-8","volume":"41","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Zhao J, Li R, Liu Y, Zhou L, Wang C, Lv C, Gao L, Cui D (2022) CircLRFN5 inhibits the progression of glioblastoma via PRRX2\/GCH1 mediated ferroptosis. J Exp Clin Cancer Res 41(1):307","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"4726_CR55","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.cell.2015.09.020","volume":"163","author":"AP Bailey","year":"2015","unstructured":"Bailey AP, Koster G, Guillermier C, Hirst EM, MacRae JI, Lechene CP, Postle AD, Gould AP (2015) Antioxidant Role for Lipid Droplets in a Stem Cell Niche of Drosophila. Cell 163(2):340\u2013353","journal-title":"Cell"},{"issue":"8","key":"4726_CR56","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/j.cmet.2021.05.016","volume":"33","author":"E Dierge","year":"2021","unstructured":"Dierge E, Debock E, Guilbaud C, Corbet C, Mignolet E, Mignard L, Bastien E, Dessy C, Larondelle Y, Feron O (2021) Peroxidation of n-3 and n-6 polyunsaturated fatty acids in the acidic tumor environment leads to ferroptosis-mediated anticancer effects. Cell Metab 33(8):1701\u20131715 e1705","journal-title":"Cell Metab"},{"issue":"1","key":"4726_CR57","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s42003-022-03538-y","volume":"5","author":"VTA Vo","year":"2022","unstructured":"Vo VTA, Kim S, Hua TNM, Oh J, Jeong Y (2022) Iron commensalism of mesenchymal glioblastoma promotes ferroptosis susceptibility upon dopamine treatment. Commun Biol 5(1):593","journal-title":"Commun Biol"},{"issue":"1","key":"4726_CR58","doi-asserted-by":"publisher","first-page":"20770","DOI":"10.1038\/s41598-024-72024-8","volume":"14","author":"S D\u2019Aprile","year":"2024","unstructured":"D\u2019Aprile S, Denaro S, Lavoro A, Candido S, Giallongo S, Torrisi F, Salvatorelli L, Lazzarino G, Amorini AM, Lazzarino G et al (2024) Glioblastoma mesenchymal subtype enhances antioxidant defence to reduce susceptibility to ferroptosis. Sci Rep 14(1):20770","journal-title":"Sci Rep"},{"issue":"7679","key":"4726_CR59","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature24297","volume":"551","author":"MJ Hangauer","year":"2017","unstructured":"Hangauer MJ, Viswanathan VS, Ryan MJ, Bole D, Eaton JK, Matov A, Galeas J, Dhruv HD, Berens ME, Schreiber SL et al (2017) Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition. Nature 551(7679):247\u2013250","journal-title":"Nature"},{"issue":"1","key":"4726_CR60","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41419-022-05532-y","volume":"14","author":"X Su","year":"2023","unstructured":"Su X, Xie Y, Zhang J, Li M, Zhang Q, Jin G, Liu F (2023) Correction: HIF-alpha activation by the prolyl hydroxylase inhibitor roxadustat suppresses chemoresistant glioblastoma growth by inducing ferroptosis. Cell Death Dis 14(1):31","journal-title":"Cell Death Dis"},{"key":"4726_CR61","doi-asserted-by":"publisher","first-page":"103220","DOI":"10.1016\/j.redox.2024.103220","volume":"73","author":"Z Miao","year":"2024","unstructured":"Miao Z, Xu L, Gu W, Ren Y, Li R, Zhang S, Chen C, Wang H, Ji J, Chen J (2024) A targetable PRR11-DHODH axis drives ferroptosis- and temozolomide-resistance in glioblastoma. Redox Biol 73:103220","journal-title":"Redox Biol"},{"issue":"8","key":"4726_CR62","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/s41419-018-0864-7","volume":"9","author":"M Buccarelli","year":"2018","unstructured":"Buccarelli M, Marconi M, Pacioni S, De Pascalis I, D\u2019Alessandris QG, Martini M, Ascione B, Malorni W, Larocca LM, Pallini R et al (2018) Inhibition of autophagy increases susceptibility of glioblastoma stem cells to temozolomide by igniting ferroptosis. Cell Death Dis 9(8):841","journal-title":"Cell Death Dis"},{"issue":"7","key":"4726_CR63","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1038\/s41418-022-00977-2","volume":"29","author":"D Moujalled","year":"2022","unstructured":"Moujalled D, Southon AG, Saleh E, Brinkmann K, Ke F, Iliopoulos M, Cross RS, Jenkins MR, Nhu D, Wang Z et al (2022) BH3 mimetic drugs cooperate with Temozolomide, JQ1 and inducers of ferroptosis in killing glioblastoma multiforme cells. Cell Death Differ 29(7):1335\u20131348","journal-title":"Cell Death Differ"},{"issue":"12","key":"4726_CR64","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1158\/1541-7786.MCR-16-0028","volume":"14","author":"MD Polewski","year":"2016","unstructured":"Polewski MD, Reveron-Thornton RF, Cherryholmes GA, Marinov GK, Cassady K, Aboody KS (2016) Increased Expression of System xc- in Glioblastoma Confers an Altered Metabolic State and Temozolomide Resistance. Mol Cancer Res 14(12):1229\u20131242","journal-title":"Mol Cancer Res"},{"issue":"7498","key":"4726_CR65","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nature13148","volume":"509","author":"JD Mancias","year":"2014","unstructured":"Mancias JD, Wang X, Gygi SP, Harper JW, Kimmelman AC (2014) Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy. Nature 509(7498):105\u2013109","journal-title":"Nature"},{"key":"4726_CR66","doi-asserted-by":"publisher","first-page":"102451","DOI":"10.1016\/j.redox.2022.102451","volume":"56","author":"K Li","year":"2022","unstructured":"Li K, Chen B, Xu A, Shen J, Li K, Hao K, Hao R, Yang W, Jiang W, Zheng Y et al (2022) TRIM7 modulates NCOA4-mediated ferritinophagy and ferroptosis in glioblastoma cells. Redox Biol 56:102451","journal-title":"Redox Biol"},{"issue":"4","key":"4726_CR67","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ccell.2022.02.003","volume":"40","author":"P Liao","year":"2022","unstructured":"Liao P, Wang W, Wang W, Kryczek I, Li X, Bian Y, Sell A, Wei S, Grove S, Johnson JK et al (2022) CD8(+) T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. Cancer Cell 40(4):365\u2013378e366","journal-title":"Cancer Cell"},{"issue":"1","key":"4726_CR68","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13046-021-02208-x","volume":"41","author":"Y Lu","year":"2022","unstructured":"Lu Y, Chan YT, Tan HY, Zhang C, Guo W, Xu Y, Sharma R, Chen ZS, Zheng YC, Wang N, Feng Y (2022) Epigenetic regulation of ferroptosis via ETS1\/miR-23a-3p\/ACSL4 axis mediates sorafenib resistance in human hepatocellular carcinoma. J Exp Clin Cancer Res 41(1):3","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"4726_CR69","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.7150\/ijbs.79853","volume":"19","author":"Q Wang","year":"2023","unstructured":"Wang Q, Gao S, Shou Y, Jia Y, Wei Z, Liu Y, Shi J, Miao D, Miao Q, Zhao C et al (2023) AIM2 promotes renal cell carcinoma progression and sunitinib resistance through FOXO3a-ACSL4 axis-regulated ferroptosis. Int J Biol Sci 19(4):1266\u20131283","journal-title":"Int J Biol Sci"},{"issue":"1","key":"4726_CR70","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41392-022-01046-3","volume":"7","author":"W Gao","year":"2022","unstructured":"Gao W, Wang X, Zhou Y, Wang X, Yu Y (2022) Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy. Signal Transduct Target Ther 7(1):196","journal-title":"Signal Transduct Target Ther"},{"issue":"9","key":"4726_CR71","doi-asserted-by":"publisher","first-page":"101706","DOI":"10.1016\/j.xcrm.2024.101706","volume":"5","author":"Y Zhong","year":"2024","unstructured":"Zhong Y, Geng F, Mazik L, Yin X, Becker AP, Mohammed S, Su H, Xing E, Kou Y, Chiang CY et al (2024) Combinatorial targeting of glutamine metabolism and lysosomal-based lipid metabolism effectively suppresses glioblastoma. Cell Rep Med 5(9):101706","journal-title":"Cell Rep Med"},{"issue":"3","key":"4726_CR72","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1158\/0008-5472.CAN-19-1577","volume":"80","author":"Y Long","year":"2020","unstructured":"Long Y, Tao H, Karachi A, Grippin AJ, Jin L, Chang YE, Zhang W, Dyson KA, Hou AY, Na M et al (2020) Dysregulation of Glutamate Transport Enhances Treg Function That Promotes VEGF Blockade Resistance in Glioblastoma. Cancer Res 80(3):499\u2013509","journal-title":"Cancer Res"},{"issue":"1","key":"4726_CR73","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12943-023-01801-2","volume":"22","author":"Y Wu","year":"2023","unstructured":"Wu Y, Song Y, Wang R, Wang T (2023) Molecular mechanisms of tumor resistance to radiotherapy. Mol Cancer 22(1):96","journal-title":"Mol Cancer"},{"issue":"1","key":"4726_CR74","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1038\/s41467-022-29905-1","volume":"13","author":"P Koppula","year":"2022","unstructured":"Koppula P, Lei G, Zhang Y, Yan Y, Mao C, Kondiparthi L, Shi J, Liu X, Horbath A, Das M et al (2022) A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers. Nat Commun 13(1):2206","journal-title":"Nat Commun"},{"issue":"17","key":"4726_CR75","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1089\/scd.2017.0123","volume":"26","author":"MD Polewski","year":"2017","unstructured":"Polewski MD, Reveron-Thornton RF, Cherryholmes GA, Marinov GK, Aboody KS (2017) SLC7A11 Overexpression in Glioblastoma Is Associated with Increased Cancer Stem Cell-Like Properties. Stem Cells Dev 26(17):1236\u20131246","journal-title":"Stem Cells Dev"},{"issue":"17","key":"4726_CR76","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1016\/j.molcel.2025.08.006","volume":"85","author":"X Liu","year":"2025","unstructured":"Liu X, Zhao Z, Bian Z, Benthani FA, Hu Y, Liang D, Jiang X (2025) Endocytosis is essential for cysteine-deprivation-induced ferroptosis. Mol Cell 85(17):3333\u20133342e3334","journal-title":"Mol Cell"},{"issue":"9","key":"4726_CR77","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1080\/15548627.2020.1810918","volume":"17","author":"X Chen","year":"2021","unstructured":"Chen X, Li J, Kang R, Klionsky DJ, Tang D (2021) Ferroptosis: machinery and regulation. Autophagy 17(9):2054\u20132081","journal-title":"Autophagy"},{"issue":"10","key":"4726_CR78","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1080\/15548627.2023.2218764","volume":"19","author":"Y Xie","year":"2023","unstructured":"Xie Y, Kang R, Klionsky DJ, Tang D (2023) GPX4 in cell death, autophagy, and disease. Autophagy 19(10):2621\u20132638","journal-title":"Autophagy"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-026-04726-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-026-04726-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-026-04726-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T05:01:56Z","timestamp":1777266116000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-026-04726-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":78,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["4726"],"URL":"https:\/\/doi.org\/10.1007\/s11064-026-04726-6","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]},"assertion":[{"value":"27 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"The patient sample transcriptome data analyzed in this study were sourced from TCGA database, with sample IDs detailed in the Supplementary Materials.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}],"article-number":"110"}}